Understanding and Managing NTM-Lung Disease

Released On
December 27, 2021

Expires On
December 26, 2022

Media Type

Completion Time
60 minutes

Infectious Disease, Pulmonology, Primary Care

Pulmonary Fibrosis, Respiratory

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by The France Foundation.


This activity is supported in part by an educational grant from Insmed.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of pulmonologists, infectious disease specialists, primary care providers, respiratory nurses/nurse practitioners/physician assistants, and other health care providers who may be involved in the management of patients with nontuberculous mycobacterial (NTM) lung disease.

Program Overview

This educational module focuses on nontuberculous mycobacterial (NTM) lung disease, its diagnosis, treatment, and patient management. An expert panel discussion, animations, and a patient’s story are highlighted within this education. This EXPLORE module has highly interactive and engaging online content, designed to allow learners to choose their own learning course.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe patient risk factors, underlying conditions, and approaches to reduce time to diagnosis
  • Develop individualized treatment goals based on patient factors
  • Discuss management of adverse events, adherence, and how to reach treatment completion
  • Review strategies to improve treatment efficacy and decrease toxicity



Keira A. Cohen, MD

Assistant Professor of Medicine
Johns Hopkins Bayview Medical Center
Baltimore, MD


Julie V. Philley, MD

Professor of Medicine, Pulmonary and Critical Care
The University of Texas at Tyler
Tyler, Texas

Physician Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

The following faculty report that they have relevant financial relationships to disclose:

Keira A. Cohen, MD

  • Non-CE Consulting Role: Hillrom, Insmed, and Microbion
  • Non-CE Speakers Bureau: Insmed
  • Contract Research: Hillrom and Insmed

Julie V. Philley, MD

  • Non-CE Consulting Role: A2N, Electromed, Hillrom, Insmed, Paratek Pharmaceuticals, RedHill Biopharma, Spero Therapeutics, and Zambon

Instructions for Participation and Credit

Technical Requirements: http://www.francefoundation.com/general-requirements.html

  1. There are no fees for participating in and receiving credit for this activity
  2. Review the activity objectives and CME/CE information
  3. Complete the CME/CE activity
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form. This form provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Credit documentation/reporting:
    • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The France Foundation (TFF) requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.


The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Copyright Information

Copyright ©2021 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission

Privacy Policy

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except when such information is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

Contact Information

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.